跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20,669 条关于
“secondary CNS lymphoma”
全部
20,669
临床试验
13,839
药物
595
机构
54
资讯
6,181
10个月前
Curis to Present Emavusertib Clinical Data in CNS Lymphoma at Society for Neuro-Oncology Meeting
10个月前
CNS Bridging Radiotherapy Shows Acceptable Safety Profile Prior to CAR-T in B-Cell Lymphoma
去年
Ibrutinib/Nivolumab Combination Shows Promising 77.8% Response Rate in Relapsed CNS Lymphoma Trial
9个月前
Miltenyi's Dual-Target CAR-T Therapy Shows Superior Efficacy in Pivotal Trial for Relapsed Large B-Cell Lymphoma
去年
CAR-T Therapy Linked to 8.9-Fold Increased Risk of Secondary T-Cell Lymphoma in Global Study
去年
Novel BTK Inhibitor Combination Shows Promise in Primary CNS Lymphoma Trial
上个月
HCT–ASCT Confirmed as Standard-of-Care Consolidation for Primary CNS Lymphoma in Landmark Phase III Trial
去年
NX-5948 Demonstrates Promising Activity in Relapsed/Refractory Waldenström Macroglobulinemia
去年
Debate Over CAR-T Therapy's Secondary Malignancy Risks Continues
去年
Alzheimer's Prevention Trials Update: Lecanemab, Donanemab, and Remternetug
第 1 页,共 619 页
上一页
下一页